Analgesia, Anesthesia, Pain, Postoperative, Thoracic
Conditions
Keywords
serratus anterior plane block, video-assisted thoracoscopic surgery, erector spinae block, postoperative analgesia
Brief summary
Objective: The authors hypothesized that combined deep and superficial serratus anterior plane block (SAPB) is as effective as erector spinae plane block (ESPB) for intraoperative and postoperative analgesia for video-assisted thoracoscopic surgery. Design: A prospective randomized controlled study. Participants: Adult patients undergoing elective video-assisted thoracoscopic surgery. Interventions: Preoperative SAPB or ESPB implementation.
Detailed description
Plane blocks implemented on preoperative course on 35 patients for each group. Postoperative Visual Analogue Scale (VAS) scores (0-10), intraoperative and postoperative analgesic consumption was measured using Mann-Whitney test. In the postoperative phase, opioid side effects, complications related to plane blocks, mobilization time and length of hospital stay was recorded and measured.
Interventions
Erector spinae plane block was implemented on preoperative course on 35 patients. Intraoperative analgesic (Fentanyl) consumption was measured for intraoperative effects of the erector spinae plane block. Postoperative Visual Analogue Scale (VAS, from 0 to 10) scores and postoperative analgesic (Morphine) consumption was measured using Mann-Whitney test.
Combined deep and superficial serratus anterior plane block was implemented on preoperative course on 35 patients. Intraoperative analgesic (Fentanyl) consumption was measured for intraoperative effects of the erector spinae plane block Postoperative Visual Analogue Scale (VAS, from 0 to 10) scores and postoperative analgesic (Morphine) consumption was measured using Mann-Whitney test.
Sponsors
Study design
Intervention model description
randomized, controlled
Eligibility
Inclusion criteria
* American Society of Anaesthesiologists (ASA) classification I-II scheduled for elective VATS
Exclusion criteria
* Patients who did not give consent * Local anaesthetic allergy * Known or suspected coagulopathy * İnfection at the injection site * History of thoracic surgery * Severe cardiovascular disease * Hepatic or renal insufficiency (glomerular filtration rate \<15 ml/min/1.73 m2) * Severe neurological or psychiatric disorders * Chronic opioid use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative analgesic effects | first 48 hours | The primary outcome is compare the postoperative analgesic effects of SAPB and ESPB applied under USG guidance before surgery in patients scheduled for VATS using VAS (Visual Analogue Scale from 0 to 10). |
| intraoperative analgesic effects | intraoperative phase | The primary outcome is compare the intraoperative analgesic effects of SAPB and ESPB applied under USG guidance before surgery in patients scheduled for VATS by measuring perioperative fentanyl consumption in both groups. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| side effects | first 48 hours | The secondary aim was to compare the opioid side effects. Patients were informed about opioid side effects and asked whether side effects were present. |
| complications | first 48 hours | The secondary aim was to compare the complications related to the applied block. Patients were examined and evaluated for any complications related to the block. |
| mobilization | first 48 hours | The secondary aim was to compare the mobilization time |
| stay of hospital | first 4 days | length of stay in the recovery unit and hospital |
Countries
Turkey (Türkiye)